🔎 Trials Near Me

Home › Asma › Texas

Studi clinici su Asma nello stato di Texas

20 studi su Asma cercano partecipanti presso sedi nello stato di Texas.

Città nello stato di Texas

Testo ufficiale dello studio (inglese)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Kerrville
In reclutamentoFase 3
Età da 12 a 17 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT05757102

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  • GSK Investigational Site, Cypress
  • GSK Investigational Site, Tomball
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07645248

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Austin
  • Research Site, Boerne
  • Research Site, Dallas
  • e altri 6
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, McKinney
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07301255

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  • Research Site 17, San Antonio
  • Research Site 07, Sugar Land
In reclutamentoFase 3
Età da 12 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07359846

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
  • Horizon Clinical Research Group, Cypress
  • Alina Clinical Trials, LLC., Dallas
  • e altri 2
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06977581

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 24, Amarillo
  • Research Site 19, Baytown
  • Research Site 07, Dallas
  • e altri 6
In reclutamentoFase 3
Età da 12 a 80 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07276724

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • Research Site, Dallas
  • Research Site, Houston
  • Research Site, San Antonio
In reclutamentoFase 3
Età da 5 a 11 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06023589

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12083, Austin
  • Teva Investigational Site 12060, Austin
  • Teva Investigational Site 12179, Cypress
  • e altri 13
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT06664619

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Lewisville
  • Research Site, San Antonio
In reclutamentoFase 2
Età da 4 a 11 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07525375

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  • GSK Investigational Site, San Antonio
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT07456033

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Austin
  • Research Site, Baytown
  • Research Site, Beaumont
  • e altri 12
In reclutamentoFase 3
Età da 12 a 17 · Tutti i sessi · Aggiornato il 13 ago 2026 · NCT06307665

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

  • GSK Investigational Site, Austin
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 60 · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT07712393

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

  • Research site, Dallas
  • Research site, Houston
  • Research site, San Antonio
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07532265

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

  • Orion Clinical Research, Austin
  • Pharmaceutical Research & Consulting, Inc., Dallas
  • Western Sky Medical Research, El Paso
In reclutamentoStudio osservazionale
Età da 5 a 100 · Tutti i sessi · Aggiornato il 2 giu 2026 · NCT07228026

Escitalopram in Asthma Patients With Frequent Exacerbation

  • UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 26 gen 2026 · NCT06216535

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

  • Baylor College of Medicine, Houston
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT06273072

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • JPS Health Network, Fort Worth
  • Kelsey Research Foundation, Houston
In reclutamentoFase 4
Età da 13 a 75 · Tutti i sessi · Aggiornato il 29 ott 2025 · NCT07052942

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

  • University of Texas at Arlington, Arlington
  • Rebuilding Together North Texas, Plano
In reclutamento
Età 5 e oltre · Tutti i sessi · Aggiornato il 29 ott 2025 · NCT07196436

Viral Mucosal Reprogramming

  • University of Texas Medical Branch, Galveston
In reclutamentoFase 2Volontari sani benvenuti
Età da 18 a 60 · Tutti i sessi · Aggiornato il 28 gen 2025 · NCT05331170

Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.